comparemela.com

Latest Breaking News On - Johno mullane - Page 1 : comparemela.com

Around the Districts: Buttevant, Freemount, Kilcorney-Dromtariffe and Lismire

Underscoring Critical Role of Science in a Smoke-Free Future, Philip Morris International Brings on Former Sanofi Exec as Chief Life Sciences Officer

Philip Morris International Underscoring Critical Role of Science in a Smoke-Free Future, Philip Morris International Brings on Former Sanofi Exec as Chief Life Sciences Officer Tuesday, January 12, 2021 11:04AM IST (5:34AM GMT)   Lausanne, Switzerland:   Philip Morris International Inc. (PMI) (NYSE: PM) today announced the appointment of Jorge Insuasty to the position of Chief Life Sciences Officer, effective Jan. 15, 2021. Mr. Insuasty will report to the company’s CEO, André Calantzopoulos.   “Jorge’s wealth of experience across both the pharmaceutical and consumer healthcare industries makes him the ideal candidate to succeed John O’Mullane, who is retiring,” said Calantzopoulos. “Jorge is a transformational leader in science and medicine and excels in driving product portfolio development through to market success. Science and a consumer-focused product portfolio are the cornerstones of our amb

Paris
France-general
France
Switzerland
David-fraser
John-omullane
Bristol-myers-squibb
Sanofi-genzyme
Jorge-insuasty
Altria-group-inc
Global-head-of-development
Drug-administration

Redirecting to Underscoring Critical Role of Science in a Smoke-Free Future, Philip Morris International Brings on Former Sanofi Exec as Chief Life Sciences Officer

January 11, 2021 finance & economy Underscoring Critical Role of Science in a Smoke-Free Future, Philip Morris International Brings on Former Sanofi Exec as Chief Life Sciences Officer Philip Morris International Inc. (PMI) (NYSE: PM) today announced the appointment of Jorge Insuasty to the position of Chief Life Sciences Officer, effective Jan. 15, 2021. Mr. Insuasty will report to the company’s CEO, André Calantzopoulos. “Jorge’s wealth of experience across both the pharmaceutical and consumer healthcare industries makes him the ideal candidate to succeed John O’Mullane, who is retiring,” said Calantzopoulos. “Jorge is a transformational leader in science and medicine and excels in driving product portfolio development through to market success. Science and a consumer-focused product portfolio are the cornerstones of our ambition to replace cigarettes with products that are a better choice than continued smoking. Jorge’s impressive track rec

Paris
France-general
France
John-omullane
Bristol-myers-squibb
Sanofi-genzyme
Jorge-insuasty
Altria-group-inc
Global-head-of-development
Drug-administration
Philip-morris-international
University-of-paris

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.